Rare diseases
Investigational molecules
Locations
Back to Bulgaria40 clinical trials in Pazardzhik, Bulgaria. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of ISIS 678354 for Patients with Severe Hypertriglyceridemia
BulgariaStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
BulgariaStudy of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes
BulgariaTesting Ulotaront Added to Antidepressants for Adults with Major Depressive Disorder Who Did Not Respond Well to Initial Treatment
BulgariaA study of ziltivekimab compared to placebo for reducing heart problems in patients who have had a heart attack
BulgariaStudy on GSK5784283 for Adults Aged 18-75 with Uncontrolled Asthma
BulgariaStudy on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis
BulgariaStudy of meropenem-vaborbactam safety and effectiveness in children aged 3 months to 12 years with complicated urinary tract infection or acute pyelonephritis
BulgariaStudy on Frexalimab for Adults with Nonrelapsing Secondary Progressive Multiple Sclerosis
BulgariaStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
BulgariaStudy on the Effectiveness and Safety of AZD4604 for Adults with Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA
BulgariaStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled
BulgariaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on innovative treatments for chronic obstructive pulmonary disease (COPD) and asthma, evaluating new therapeutic approaches and medications to improve patient outcomes.
Multiple trials are exploring both established and novel therapeutic options for patients with moderate to severe respiratory conditions.
Groundbreaking research in multiple sclerosis and seizure management, with trials evaluating new therapeutic agents and treatment approaches for various neurological conditions.
Studies are investigating both progressive and relapsing forms of neurological conditions to develop more effective treatments.
Innovative research targeting heart failure and stroke prevention, including studies on new medications for atrial fibrillation and post-stroke care.
These trials aim to improve cardiovascular outcomes and reduce the risk of serious complications in high-risk patients.
Advanced research in schizophrenia and Alzheimer's disease psychosis, focusing on novel therapeutic approaches and long-term treatment solutions.
Trials are exploring new therapeutic options to address both acute symptoms and long-term disease management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
